|
Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common …
MarketWatch Separately, $1.0 million recently invested in the Company privately by an existing investor converted into 400,000 units, consisting of 400,000 shares of common stock and warrants to purchase up to 100,000 shares of common stock at the same term as the … |
